Researchers develop stable compound for targeted alpha therapy in prostate cancer

  • Post author:
  • Post category:uncategorized

Compounds containing astatine-211 (211At) can be used in targeted radiotherapies for prostate cancer, but deastatination in the body remains a significant hurdle.